The Daiichi deal will help the company emerge as a global research firm, says the Ranbaxy management, reports CNBC-TV18. Ranbaxy is expected to become a subsidiary of Daiichi. Daiichi will fund the stake buy via internal accruals and debt, added the Ranbaxy management
Wednesday, June 11, 2008
Subscribe to:
Post Comments (Atom)
DISCLAIMER
DISCLAIMER: INVESTING AND TRADING IS VERY RISKY AND FINANCIAL LOSSES ARE OFTEN THE RESULT.
Investment success is far from a sure thing. This site is solely intended for educational purposes. I am not a registered investment advisor and it is not my intention to provide anyone with investment advice. I am not recommending that any reader of this blog buy, sell, short, or engage in any other investment strategy based upon the content set forth herein. I strongly urge all readers to perform their own due diligence before investing and or trading their funds. I will not be responsible for any readers financial losses.
0 comments:
Post a Comment